@Max095 The aim is to be profitable by 2028 and make a profit of USD 127 million. Next year, turnover will actually fall. But then the aim is to increase turnover from million dollars. The aim is to improve vision by means of a walking teraphy. There is something in phase 1, 2 and also 3. As soon as studies are successful and approvals are obtained, the share could take off. But it's all speculative.
The share had the big hype due to the corona vaccine in India. Then there was the crash.